CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells
Circulation - United States
doi 10.1161/circulationaha.106.644518
Full Text
Open PDFAbstract
Available in full text
Date
November 14, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)